Director of Licensing and Subscription Sales needed for this Medical Publishing Company. The company’s mission is to develop and provide services that fulfill the news and news analysis needs of the pharmaceutical industry.
Established as an email newsletter in 2002, this company now publishes daily, and serves as a personalizable business intelligence resource designed for the busy pharmaceutical professional. It is a time-saving tool keeping subscribers abreast of international developments affecting the pharmaceutical industry, in addition to providing subscribers with regulatory, product, and company news relevant to their interests. This company now reaches over 130,000 subscribers on a daily basis and circulation continues to grow at a fast pace.
Part of a group of companies that comprise one of the largest healthcare knowledge networks in the world, this firm has an enviable amount of talent and resources at its disposal giving it a competitive advantage in the global pharmaceutical information market. This company is well positioned to grow exponentially in the coming years with unique access to industry and medical audiences and with a reputation for quality and innovation.
This is a challenging role where the potential rewards are high. The objectives will be to identify and build new accounts, provide outstanding client service and grow business in existing accounts. As a growth business unit, this company is an entrepreneurial, client-focused culture and resourcefulness and perseverance are key. We are looking for someone with an ability to build strong and productive relationships with a wide network of clients.
Candidates with business development experience in the area of subscription services will be preferred. However, above all, we are looking for someone who has the drive and determination to be the best business developer/manager in the field.
Objectives and Responsibilities:
The overarching objective is to achieve exponential growth in clients, account yield and overall sales through the development of accounts in pharma, from small to large.